Enfusion Inc.

NYS: ENFN

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Enfusion Inc.

Market open

--Real time quotes

May 20, 2022, 1:50 p.m.

ENFN

/zigman2/quotes/230006699/composite

9.29

Change

+0.20 +2.15%

Volume

Volume 160,858

Real time quotes

/zigman2/quotes/230006699/composite

Previous close

$ 9.09

$ 9.29

Change

+0.20 +2.15%

Day low

Day high

$8.91

$9.43

52 week low

52 week high

$7.80

$23.21

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Enfusion Inc.

View Ratios

Fiscal year is January-December. All values USD millions.			2019	2020	2021	5-year trend
Sales/Revenue	-	-	59.03M	79.57M	111.7M
Sales Growth	-	-	-	34.79%	40.39%
Cost of Goods Sold (COGS) incl. D&A	-	-	16.96M	21.36M	31.85M
COGS excluding D&A	-	-	15.8M	19.07M	27.87M
Depreciation & Amortization Expense	-	-	1.16M	2.29M	3.98M
Depreciation	-	-	1.16M	2.29M	3.98M
Amortization of Intangibles	-	-	-	-	-
COGS Growth	-	-	-	25.92%	49.10%
Gross Income	-	-	42.07M	58.21M	79.86M
Gross Income Growth	-	-	-	38.37%	37.19%
Gross Profit Margin	-	-	-	-	71.49%	NA

			2019	2020	2021	5-year trend
SG&A Expense	-	-	28.2M	52.13M	355.74M
Research & Development	-	-	4.15M	6.32M	153.4M
Other SG&A	-	-	24.05M	45.82M	-
SGA Growth	-	-	-	84.89%	582.37%
Other Operating Expense	-	-	-	-	-
Unusual Expense	-	-	-	-	1.22M
EBIT after Unusual Expense	-	-	-	-	(277.1M)
Non Operating Income/Expense	-	-	(3,000)	82,000	30,000
Non-Operating Interest Income	-	-	-	-	-
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	-	-	724,000	1.66M	4.59M
Interest Expense Growth	-	-	-	129.56%	176.41%
Gross Interest Expense	-	-	724,000	1.66M	4.59M
Interest Capitalized	-	-	-	-	-
Pretax Income	-	-	13.14M	4.49M	(281.66M)
Pretax Income Growth	-	-	-	-65.80%	-6,367.53%
Pretax Margin	-	-	-	-	-252.16%	NA
Income Tax	-	-	486,000	433,000	579,000
Income Tax - Current Domestic	-	-	-	-	-
Income Tax - Current Foreign	-	-	-	-	228,000
Income Tax - Deferred Domestic	-	-	-	-	-
Income Tax - Deferred Foreign	-	-	-	-	351,000
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	-	-	12.66M	4.06M	(282.24M)
Minority Interest Expense	-	-	-	-	(123.93M)
Net Income	-	-	12.66M	4.06M	(158.32M)
Net Income Growth	-	-	-	-67.91%	-3,998.47%
Net Margin Growth	-	-	-	-	-141.73%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	-	-	12.66M	4.06M	(158.32M)
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	-	-	12.66M	4.06M	(158.32M)
EPS (Basic)	-	-	0.11	0.04	(1.40)
EPS (Basic) Growth	-	-	-	-67.95%	-4,000.84%
Basic Shares Outstanding	-	-	113.05M	113.05M	113.05M
EPS (Diluted)	-	-	0.11	0.04	(1.40)
EPS (Diluted) Growth	-	-	-	-67.95%	-4,000.84%
Diluted Shares Outstanding	-	-	113.05M	113.05M	113.05M
EBITDA	-	-	15.03M	8.37M	(271.91M)
EBITDA Growth	-	-	-	-44.33%	-3,350.56%
EBITDA Margin	-	-	-	-	-243.43%	NA

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and Cookie Notice ().
Do Not Sell My Personal Information

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Enfusion Inc.

Annual Financials for Enfusion Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk